Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.


Autoria(s): Lausch E.; Janecke A.; Bros M.; Trojandt S.; Alanay Y.; De Laet C.; Hübner C.A.; Meinecke P.; Nishimura G.; Matsuo M.; Hirano Y.; Tenoutasse S.; Kiss A.; Rosa R.F.; Unger S.L.; Renella R.; Bonafé L.; Spranger J.; Unger S.; Zabel B.; Superti-Furga A.
Data(s)

2011

Resumo

Vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases are the hallmarks of the genetic disorder spondyloenchondrodysplasia. We mapped a locus in five consanguineous families to chromosome 19p13 and identified mutations in ACP5, which encodes tartrate-resistant phosphatase (TRAP), in 14 affected individuals and showed that these mutations abolish enzyme function in the serum and cells of affected individuals. Phosphorylated osteopontin, a protein involved in bone reabsorption and in immune regulation, accumulates in serum, urine and cells cultured from TRAP-deficient individuals. Case-derived dendritic cells exhibit an altered cytokine profile and are more potent than matched control cells in stimulating allogeneic T cell proliferation in mixed lymphocyte reactions. These findings shed new light on the role of osteopontin and its regulation by TRAP in the pathogenesis of common autoimmune disorders.

Identificador

http://serval.unil.ch/?id=serval:BIB_8559E4EB9D44

isbn:1546-1718 (Electronic)

pmid:21217752

doi:10.1038/ng.749

isiid:000286623800011

Idioma(s)

en

Fonte

Nature Genetics, vol. 43, no. 2, pp. 132-137

Tipo

info:eu-repo/semantics/article

article